Levetiracetam Tablet, Film Coated
Product Images NDC 82009-121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 82009-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levefig1 (Levefig1)

Levefig1 (Levefig1)
A bar chart showing percentages of patients in three groups: placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The chart compares patient response rates, with Levetiracetam groups showing higher percentages compared to placebo.*
FDA Label Image

Levefig2 (Levefig2)

Levefig2 (Levefig2)
A bar chart showing percentages of patients across three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). Each bar represents the percentage of patients in the respective treatment group, with patient counts noted below each group label.*
FDA Label Image

Levefig3 (Levefig3)

Levefig3 (Levefig3)
A bar chart comparing the percentage of patients responding to placebo versus Levetiracetam 3000 mg/day. The chart shows approximately 14.4% response for placebo (N=104) and about 39.4% response for Levetiracetam 3000 mg/day (N=180).*
FDA Label Image

Levefig4 (Levefig4)

Levefig4 (Levefig4)
A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The chart shows about 19.6% of patients for placebo (N=87) and 44.6% for Levetiracetam (N=101).*
FDA Label Image

Levefig5 (Levefig5)

Levefig5 (Levefig5)
Bar chart comparing the percentage of a certain outcome between two groups: Placebo (N=64) at 45.2% and Levetiracetam (N=79) at 72.2%. The chart shows a notable increase for Levetiracetam over Placebo.*
FDA Label Image

Levefig6 (Levefig6)

Levefig6 (Levefig6)
This bar chart compares the withdrawal percentages between two groups: Placebo (N=64) and Levetiracetam (N=79). The vertical axis represents withdrawal percentage, with the Placebo group at 45.2% and the Levetiracetam group at 72.2%.*
FDA Label Image

Levestructure (Levestructure)

Levestructure (Levestructure)
Chemical structure diagram of Levetiracetam, showing its molecular composition and bonds.*
FDA Label Image

Levetiracetamtabs1000mg60 (Levetiracetamtabs1000mg60)

Levetiracetamtabs1000mg60 (Levetiracetamtabs1000mg60)
Levetiracetam Tablets USP 1000 mg film-coated oral tablets packaging label from Quallent Pharmaceuticals Health LLC. The label indicates 60 tablets per container, includes a barcode, storage instructions at 20° to 25°C, and pharmacist dispensing guidance. Manufactured by Annora Pharma Pvt. Ltd., India. Contains a red boxed pharmacist attention statement regarding the medication guide.*
FDA Label Image

Levetiracetamtabs250mg500 (Levetiracetamtabs250mg500)

Levetiracetamtabs250mg500 (Levetiracetamtabs250mg500)
Label for Levetiracetam Tablets USP 250 mg by Quallent Pharmaceuticals Health LLC. The film-coated oral tablet label indicates each tablet contains 250 mg levetiracetam. The package size is 500 tablets. The label includes storage instructions, medication guide requirements, barcode, and manufacturer information including Annora Pharma Pvt. Ltd. in India.*
FDA Label Image

Levetiracetamtabs500mg500 (Levetiracetamtabs500mg500)

Levetiracetamtabs500mg500 (Levetiracetamtabs500mg500)
Label for Levetiracetam Tablets, USP 500 mg film-coated oral tablets. The label indicates a package containing 500 tablets, manufactured for Quallent Pharmaceuticals Health LLC by Annora Pharma Pvt. Ltd. It includes storage instructions and a pharmacist advisory about dispensing with a child-resistant closure.*
FDA Label Image

Levetiracetamtabs750mg500 (Levetiracetamtabs750mg500)

Levetiracetamtabs750mg500 (Levetiracetamtabs750mg500)
Label for Levetiracetam Tablets USP 750 mg, film-coated oral tablets. The label shows the product name, strength, quantity of 500 tablets, and NDC 82009-123-05. It is manufactured for Quallent Pharmaceuticals Health LLC by Annora Pharma Pvt. Ltd. The label includes storage instructions, a barcode, and contact information for Quallent Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.